The Voice of the Industry
03/22/2024
Cryoport Systems Talks Leveraging Supply Chain Visibility Technologies with Pharmaceutical Outsourcing
Strong visibility into your advanced medicine supply chain is necessary to meet the life sciences industry’s strict quality requirements and maintain therapy viability.
03/15/2024
0% Failure Rate: Our Support of Certainty Featured by gasworld
Mark Sawicki, Cryoport Systems’ Chief Executive Officer, recently explained how Cryoport Systems operates on a 0% failure rate to support the complex and ever-evolving life sciences industry.
11/27/2023
Uniting a Cell and Gene Kingdom in Article with the Medicine Maker
Both Cryoport Systems’ own Robert Jones, Vice President of Global BioServices, and Mark Sawicki, President, CEO, and Chief Scientific Officer, shared details of our recently announced...
07/10/2023
Location, infrastructure boost NJ’s biotech, life sciences industries
NJBIZ interviewed Cryoport Systems’ CEO, Mark Sawicki, about Cryoport Systems’ expansion into BioServices and our Morris Plains, NJ facility location in an article...
04/27/2023
Standardize for Success with Mark Sawicki for The Medicine Maker
Dr. Mark Sawicki, Cryoport System’s CEO, shared his expertise on the future of regenerative medicine and the top challenges facing the industry today with The Medicine Maker.
01/18/2023
New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
Cryoport, Inc. is excited to announce a new strategic partnership with Syneos Health, a fully integrated biopharmaceutical solutions organization.
12/02/2022
Life Sciences Review Awards MVE Bio The Top Clinical Lab Equipment Company
A salient aspect of biological research concerns collecting and preserving biological samples and materials for analysis. Since samples often degrade in the time between collection and analysis...
07/01/2022
